NUWE
NUWE
NASDAQ · Health Care

Nuwellis Inc

$5.03
-0.50 (-9.04%)
Financial Highlights (FY 2026)
Revenue
2.07B
Net Income
-4,384,267,685
Gross Margin
62.0%
Profit Margin
-211.9%
Rev Growth
-1.1%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 62.0% 62.0% 65.6% 65.6%
Operating Margin -134.3% -120.9% 16.7% 18.0%
Profit Margin -211.9% -201.3% 10.7% 13.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.07B 2.09B 456.0K 484.3K
Gross Profit 1.28B 1.30B 299.0K 317.5K
Operating Income -2,778,992,382 -2,528,144,287 76.2K 87.3K
Net Income -4,384,267,685 -3,988,518,059 48.7K 63.4K
Gross Margin 62.0% 62.0% 65.6% 65.6%
Operating Margin -134.3% -120.9% 16.7% 18.0%
Profit Margin -211.9% -201.3% 10.7% 13.1%
Rev Growth -1.1% -1.1% -2.2% -1.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 1.39M 1.38M
Total Equity — — 2.40M 2.33M
D/E Ratio — — 0.58 0.59
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -2,729,000,840 -2,620,591,123 88.9K 91.7K
Free Cash Flow — — 29.4K 36.1K